Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03903588 · ClinicalTrials.gov registry record
The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 86
- Enrollment target
NCT03903588: Completed study, sponsored by Heidelberg Engineering.
NCT03903588 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03903588 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess two grids.
Primary Outcome
Measurement of the thickness of Retinal layers thickness to assess 2 grids
Interventions
- DEVICE Optical Coherence Tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2019-09-12 |
What the finished NCT03903588 record still lists
NCT03903588 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Optical Coherence Tomography is the first listed.
NCT03903588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03903588 about?
NCT03903588 is a clinical study titled "The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study". This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess two grids.
What is the current status of trial NCT03903588?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2019-03-22. Estimated completion is 2019-09-12.
What interventions are being tested in trial NCT03903588?
The interventions under investigation include: Optical Coherence Tomography (DEVICE).
Who is sponsoring clinical trial NCT03903588?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI